Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Genentech's NGF disappointing in phase III trial

April 13, 1999

Small-molecule thrombopoietic compounds in development at Kyowa Hakko

April 13, 1999

Sertoli and JDF enter cellular therapy collaboration for type I diabetes

April 12, 1999

Selective, orally active beta3-adrenoceptor agonists identified at Merck

April 9, 1999

New class of potent, selective human glucagon receptor antagonists presented by Merck

April 9, 1999

Peptidomimetic GH secretagogues synthesized under Japanese-U.S. collaboration

April 9, 1999

Inhibitors of MTP from Wakunaga claimed for lipoprotein disorders

April 8, 1999

Generex's buccal insulin effective in short-term clinical trials

April 8, 1999

U.S. patent issues to RCT for novel diabetes vaccine

April 8, 1999

AutoImmune and Lilly to restructure collaborative agreement for diabetes treatment

April 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...